← Back to Search

Contact Lens

Refit for Near-sightedness (FOX Trial)

N/A
Recruiting
Led By Lyndon Jones, PhD, FCOptom
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 14+2
Awards & highlights

FOX Trial Summary

This trial aims to see how well DAILIES TOTAL1 daily disposable contact lenses work for people who use digital devices a lot (at least eight hours a day). They will focus on how comfortable the

Who is the study for?
This trial is for people aged 18-40 who use digital devices like smartphones or computers for at least 8 hours a day. They must be current daily wearers of soft contact lenses, have near-sightedness within specific limits, and can commit to wearing DAILIES TOTAL1 contacts for over 13 hours daily.Check my eligibility
What is being tested?
The study tests the performance of DAILIES TOTAL1 disposable contact lenses in individuals who frequently use digital screens. It focuses on comfort, dryness, and vision quality while using these lenses.See study design
What are the potential side effects?
While not explicitly stated here, common side effects from wearing contact lenses may include eye discomfort or dryness, red eyes, blurry vision, and a feeling of something in the eye.

FOX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 14+2
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 14+2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjective Rating of Clarity of Vision After 8 Hours or More of Digital Device Use
Subjective Rating of Comfort After 8 Hours or More of Digital Device Use
Subjective Rating of Dryness After 8 Hours or More of Digital Device Use

FOX Trial Design

1Treatment groups
Experimental Treatment
Group I: RefitExperimental Treatment1 Intervention
Refit and dispense participant with delefilcon A contact lenses and evaluate lens performance
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Delefilcon A contact lenses
2023
N/A
~1040

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
124 Previous Clinical Trials
209,323 Total Patients Enrolled
Alcon ResearchIndustry Sponsor
704 Previous Clinical Trials
124,476 Total Patients Enrolled
Lyndon Jones, PhD, FCOptomPrincipal InvestigatorCentre for Ocular Research & Education
12 Previous Clinical Trials
426 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this clinical investigation?

"To be eligible for enrollment, individuals must exhibit myopia and fall within the age range of 18 to 40 years. A maximum of 35 participants will be accepted into this study."

Answered by AI

Are individuals above the age of 65 being actively sought for participation in this medical study?

"Enrollment in this trial is restricted to individuals aged 18 and below 40 years."

Answered by AI

What is the current number of individuals who have been admitted into this clinical research study?

"Affirmative. The details on clinicaltrials.gov reveal that this medical study is presently in search of participants. Originally shared on March 18, 2024, the trial was most recently revised on March 21, 2024. The objective is to enroll a total of 35 patients from one designated site."

Answered by AI

Are individuals currently able to participate in this ongoing medical study?

"Indications from clinicaltrials.gov reveal that this current trial is actively seeking participants. Initially shared on March 18, 2024 and most recently revised on March 21, 2024, the study aims to recruit a total of 35 individuals at one designated site."

Answered by AI
~17 spots leftby Jul 2024